- Home
- EYPT vs NATH Comparison
EYPT vs NATH Comparison
Compare EYPT & NATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EYPT
- NATH
- Stock Information
- Founded
- EYPT 1987
- NATH 1916
- Country
- EYPT United States
- NATH United States
- Employees
- EYPT N/A
- NATH N/A
- Industry
- EYPT Biotechnology: Laboratory Analytical Instruments
- NATH Restaurants
- Sector
- EYPT Industrials
- NATH Consumer Discretionary
- Exchange
- EYPT Nasdaq
- NATH Nasdaq
- Market Cap
- EYPT 484.4M
- NATH 385.4M
- IPO Year
- EYPT 2005
- NATH N/A
- Fundamental
- Price
- EYPT $8.25
- NATH $106.80
- Analyst Decision
- EYPT Strong Buy
- NATH
- Analyst Count
- EYPT 8
- NATH 0
- Target Price
- EYPT $24.29
- NATH N/A
- AVG Volume (30 Days)
- EYPT 895.1K
- NATH 34.9K
- Earning Date
- EYPT 05-07-2025
- NATH 06-11-2025
- Dividend Yield
- EYPT N/A
- NATH 1.87%
- EPS Growth
- EYPT N/A
- NATH 24.88
- EPS
- EYPT N/A
- NATH 5.80
- Revenue
- EYPT $56,042,000.00
- NATH $146,386,000.00
- Revenue This Year
- EYPT N/A
- NATH N/A
- Revenue Next Year
- EYPT N/A
- NATH N/A
- P/E Ratio
- EYPT N/A
- NATH $18.24
- Revenue Growth
- EYPT 12.04
- NATH 6.83
- 52 Week Low
- EYPT $3.91
- NATH $66.35
- 52 Week High
- EYPT $13.99
- NATH $107.00
- Technical
- Relative Strength Index (RSI)
- EYPT 72.87
- NATH 62.65
- Support Level
- EYPT $5.46
- NATH $102.60
- Resistance Level
- EYPT $8.36
- NATH $107.00
- Average True Range (ATR)
- EYPT 0.57
- NATH 3.14
- MACD
- EYPT 0.24
- NATH 0.07
- Stochastic Oscillator
- EYPT 96.21
- NATH 97.21
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.
About NATH Nathan's Famous Inc.
Nathan's Famous Inc is an owner of fast food franchises in the United States. The company's reportable segment includes the Branded Product Program, Product licensing, Restaurant operations and Corporate. Branded Product Program derives revenue principally from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors who resell the products to foodservice operators. It generates maximum revenue from the Branded Product Program segment. Geographically, it derives a majority of revenue from the United States.